Table 3.
Mean (±s.d.) for body mass and pharmacokinetic parameters in responders and nonresponders, both in the 2 mg and the 4 mg group.

Mean (±s.d.) for body mass and pharmacokinetic parameters in responders and nonresponders, both in the 2 mg and the 4 mg group.
